GlassScriptPhysician profile
Jonathan J Loewen
NPI 1306860507
$988.94
in general payments reported to CMS, 2019-2025
19 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.64 · 2020: $15.00 · 2021: $160 · 2022: $146 · 2023: $244 · 2024: $97.28 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $127.08 | 2019-2025 | Blueprint Patient Specific Instrumentation |
| Linvatec Corporation | $119.29 | 2022-2025 | Linvatec Extremities, Linvatec Arthroscopy, Y-Knot |
| Bioventus LLC | $98.03 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $78.56 | 2021-2022 | |
| Acumed LLC | $78.09 | 2023-2024 | Inframe Implant, Innate Implant, Acumed |
| Depuy Synthes Sales INC. | $68.29 | 2023-2025 | Inhance, Lcp, Na |
| Encore Medical, LP | $63.74 | 2023-2024 | Djo Surgical |
| Kowa Pharmaceuticals America, INC. | $56.73 | 2022-2023 | Seglentis |
| Titan Surgical Group, LLC | $55.22 | 2023-2025 | |
| Microport Orthopedics INC | $39.60 | 2025 | Mpo Medial Pivot Knee |
| Vertex Pharmaceuticals Incorporated | $33.61 | 2025 | |
| Heron Therapeutics, INC. | $29.21 | 2024 | Zynrelef |
| Horizon Therapeutics Plc | $27.83 | 2020-2021 | |
| Orthalign INC | $25.56 | 2025 | Orthalign Plus |
| Pacira Pharmaceuticals Incorporated | $24.10 | 2024 | Exparel, Iovera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $17.95 | 2025 | Hymovis |
| Zyla Life Sciences, INC. | $16.13 | 2019 | |
| Pacira Therapeutics, INC. | $15.71 | 2019 | |
| Smith+Nephew, INC. | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Loewen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.